Guide for Pharmaceutical Manufacturing Industry Research & Development Medical Pharmacy Students FDA updates Guidelines
Custom Search

Sunday, October 7, 2012

Anti HIV drug nelfinavir exhibits anticancer activity against HER2 positive breast cancer cells

Anti-cancer activity of an anti retroviral drug:

Nelfinavir is a drug used in treatment of HIV infection to lower the HIV viral load. It is an enzyme inhibitor drug which inhibit an enzyme which breakdown protein from human cells in to in to small units, which are then used for formation of HIV viron capsule and rest of proteins responsible for activity of HIV. The enzyme is known as retroviral aspartyl protease, and the drug is known as protease inhibitor.

Simillar approach is also adapted in treatment of Hepatitis C and drugs used for the purpose are Boceprevir and Telaprevir.

The drug Nelfinavir is also being studied extensively for its activity against various cancer cell invitro, and it is found that it can facilitate killing of cancer cell (Apoptosis) when combined with radiation therapy.

Breast cancer is one of big reason for loses of lives in world wide of which breast cancer which is positive of Human Epidermal Growth Factor Receptor 2 is most difficult to treat and its progression is rapid.

Researchers at Johns Hopkins School of Medicine have studied effect of Nelfinavir on HER2 positive breast cancer in vitro over which they found satisfactory and later on confirmed the same in mice model, the concentration of drug required to bring about anticancer activity is almost similar to the existing dosage required for its antiretroviral activity.

This finding can be explored to develop more effective drug for HER2 positive breast cancer by developing analog drugs similar to Nelfinavir.

Other protease inhibitor drugs are ritonavir, indinavir, amprenavir,saquinavir, nelfinavir.

No comments:

Like This Website on Facebook and Stay Connected Share This Article with your Friends

Latest Pharma Update

USFDA approves first drug Inmazeb to treat Ebola Virus Infection

US FDA approved first drug to treat Ebola Virus Infection (zaire ebolavirus) . So far there was no drug treatment available for Ebola virus ...

You May Also Like

If you are looking for latest Pharmaceutical Manufacturing Guidelines of USFDA, UKMHRA, TGA WHO GMP then this website is one of most popular source.
Subscribe to this website by providing your email

Enter your email address get latest Pharma Guideline and technology update by email whenever this website is updated